Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study.
about
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyComparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyCombating disease mongering: daunting but nonetheless essential.Antihypertensive and lipid lowering treatment in 70-74 year old individuals--predictors for treatment and blood-pressure control: a population based survey. The Hordaland Health Study (HUSK).Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 populationDevelopment and pilot of an internationally standardized measure of cardiovascular risk management in European primary care.Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study.Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.What professional activities do general practitioners find most meaningful? Cross sectional survey of Norwegian general practitioners.Family physicians' management of genetic aspects of a cardiac disease: a scenario-based study from slovenia.Cancer worry among Norwegian male BRCA1/2 mutation carriers.Critiques of the risk concept--valid or not?Cardiovascular risk assessment of Bulgarian urban population: cross-sectional studyEuropean Practice Assessment of Cardiovascular risk management (EPA Cardio): protocol of an international observational study in primary care.Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population.Individualized population care: linking personal care to population care in general practice.Person-centered prevention and health promotion.Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000-2001.Clinical Gaze in Risk-Factor Haze: Swedish GPs' Perceptions of Prescribing Cardiovascular Preventive Drugs.Promotion of disease and corrosion of medicine.Thresholds for normal blood pressure and serum cholesterol.Too much health care and too little care for the sick?Addressing the future role of general practice at the 16th Nordic Congress in Copenhagen 2009: how can we ensure sustainable care in a complex world of evidence, context, organization, and personal care?Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.Women at risk of coronary heart disease experience barriers to diagnosis and treatment: a qualitative interview study.Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014.Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension.The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population.More illness and less disease? A 20-year perspective on chronic disease and medication
P2860
Q26782126-013622C6-7D86-4631-BC41-3DECD12159EBQ28677533-83385D8B-1DB4-41BB-A182-5D6085297A6DQ33238996-A922BEB2-35DC-4DC3-8AA3-FF0E421F2515Q33260919-DC04C789-04AC-45F8-822D-5265DBBA3E15Q33514099-01EAA185-DEEC-42B1-8842-3A70B84F5866Q33865199-2873DA0D-C9AB-499D-B49E-609038D7684CQ33944736-C5EB636E-68DF-4183-BB91-CA758361D1ADQ34032851-BF0CA898-92D8-477A-9B5C-97F6953FD354Q34632960-33C867E7-8CE2-4DE6-BC1F-BDB6A32507E5Q35140830-99C5A036-0CD6-4863-8FF2-A817EDEB2D6DQ35219186-F4C9AC40-9E90-4799-A7EA-BC52C12A22F9Q36939706-29D5E2F3-0E2B-4D6B-A47F-42B664917AFDQ37051929-51928CCE-9355-4BC8-9475-7BA36EBEB0EFQ37064700-8D99A2C0-E2CE-4E13-892E-92E64201FC94Q37226156-67B45121-B4EC-4C5B-8959-83AF266288E1Q37329292-32BD7E5D-F9EE-41F0-BDCF-55BD320D2FB3Q39498890-357A703B-8F10-4188-8109-0B673FB265FCQ40326093-21D71144-109D-4BF7-BF65-8F53B8A18602Q42355495-8AF8AA2A-E890-4158-A28E-0E03FDA2E57AQ42407816-36C37277-E689-48A6-BFB6-7D7DB07A560BQ43065365-D15BC9F7-E27C-46F9-ABA7-6FD67E07CC90Q43201122-7DABF71B-D47C-469A-A367-D01C0FF17E57Q43233199-B035BBD3-53AD-44CB-95D2-C16066414BFBQ43665398-CDAB6832-165E-48C2-807A-E30EDB190F90Q46933058-ECB91917-5C87-499C-B6D2-ABB94034106CQ47648788-2564BBB5-4533-4697-B83C-F896868369CAQ48508112-603A7C82-71D9-4F96-97A8-3A57A1EB7CACQ49043410-3F3E22E6-66D1-488B-97D6-C3AEEC4F47D3Q50789755-E6BDCE97-886E-452C-BD0F-F7290EE2BB34Q59313803-96A50054-AD43-410E-8218-9FEDAA637346
P2860
Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Ethical dilemmas arising from ...... riptive epidemiological study.
@en
Ethical dilemmas arising from ...... riptive epidemiological study.
@nl
type
label
Ethical dilemmas arising from ...... riptive epidemiological study.
@en
Ethical dilemmas arising from ...... riptive epidemiological study.
@nl
prefLabel
Ethical dilemmas arising from ...... riptive epidemiological study.
@en
Ethical dilemmas arising from ...... riptive epidemiological study.
@nl
P2093
P2860
P1476
Ethical dilemmas arising from ...... riptive epidemiological study.
@en
P2093
Irene Hetlevik
Solfrid Romundstad
P2860
P304
P356
10.1080/02813430410006693
P577
2004-12-01T00:00:00Z